HedgeChatter

  • Home /
  • Tag Archives

OMED

8:36 am OncoMed Pharma commences third Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with carboplatin and paclitaxel in ovarian cancer; all six planned Wnt-pathway Phase 1b studies now underway

moreView todays social media effects on OMEDView the latest stocks trending across Twitter. Click to view dashboardSee who OncoMed is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on 8:36 am OncoMed Pharma commences third Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with carboplatin and paclitaxel in ovarian cancer; all six planned Wnt-pathway Phase 1b studies now underway read more

OncoMed Pharmaceuticals Commences Third Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Carboplatin and Paclitaxel in Ovarian Cancer

[GlobeNewswire] – REDWOOD CITY, Calif. — OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced the initiation … moreView todays social media effects on OMEDView the latest stocks trending across Twitter. Click to view dashboardSee who OncoMed is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on OncoMed Pharmaceuticals Commences Third Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Carboplatin and Paclitaxel in Ovarian Cancer read more

8:32 am OncoMed Pharma initiates second Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with Sorafenib (Nexavar(R)) in Hepatocellular Cancer

moreView todays social media effects on OMEDView the latest stocks trending across Twitter. Click to view dashboardSee who OncoMed is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on 8:32 am OncoMed Pharma initiates second Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with Sorafenib (Nexavar(R)) in Hepatocellular Cancer read more

OncoMed Pharmaceuticals Initiates Second Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Sorafenib (Nexavar(R)) in Hepatocellular Cancer

[GlobeNewswire] – REDWOOD CITY, Calif. — OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that it has … moreView todays social media effects on OMEDView the latest stocks trending across Twitter. Click to view dashboardSee who OncoMed is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on OncoMed Pharmaceuticals Initiates Second Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Sorafenib (Nexavar(R)) in Hepatocellular Cancer read more